Key facts
- This page summarizes David B. Wells's Form 4 filing for Trade Desk, Inc. (TTD).
- 25 reported transactions and 12 derivative rows are listed below.
- Accepted by SEC: 15 May 2025, 17:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
These sales represent the aggregate shares from the twelve acquisitions reported above.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F3
This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
Footnote F4
The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
Footnote F5
This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
Footnote F6
This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
Footnote F7
The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
Footnote F8
This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021.
Footnote F9
The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
Footnote F10
The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
Footnote F11
The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
Footnote F12
The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.
Footnote F13
The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date.
Footnote F14
The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date.
Footnote F15
The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date.